Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Mestanolone | HCID 10633 | — |
| Reactant | 2-Iodoxybenzoic acid | HCID 108794 | — |
| Product | Methyl-1-testosterone | HCID 7092657 | — |
Reaction Steps
In yet another aspect of the present invention, mestanolone is reacted with IBX to form 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one. The 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one is reacted with osmium tetroxide and N-methylmorpholine N-oxide to form 1α, 2α, 17β-trihydroxy-17α-methylandrostan-3-one. The 1α, 2α, 17β-trihydroxy-17α-methylandrostan-3-one is reacted with sodium metaperiodate to form 17β-hydroxy-17α-methyl-1-oxo-1,2,-seco-A-nor-5α-androstan-2-oic acid. Oxandrolone is then formed from the 17β-hydroxy-17α-methyl-1-oxo-1,2,-seco-A-nor-5α-androstan-2-oic acid by reacting the 17β-hydroxy-17α-methyl-1-oxo-1,2,-seco-A-nor-5α-androstan-2-oic acid with sodium borohydride followed by an acid treatment comprising addition of hydrochloric acid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07009063B2 |
|---|
| Source dataset | uspto-grants-2006_03 |
|---|
| ORD ID | ord-ff352d4c529346f8b4b6a7c0175f7641 |
|---|
| Source note | uspto-grants-2006_03 |
|---|